At Best Startup UK we track over 130,000 UK startups and over 500,000 people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United Kingdom based CEO’ operating in the Medical Device space. If you think a CEO’ is missing from this list, feel free to contact our editor on editor@beststartup.co.uk.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Companies House UK, Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Kevin Lee
Chief Executive Officer of Bicycle Therapeutics
Kevin Lee, Ph.D., MBA, is chief executive officer of Bicycle Therapeutics. Kevin joined Bicycle Therapeutics from Pfizer, where he served as senior vice president and chief scientific officer of the Rare Disease Research Unit. In that role, he held responsibility for more than 20 novel programmes across the full spectrum of research and development, established Pfizer’s rare disease strategy, conceptualized and implemented the company’s gene therapy strategy with the creation of the Genetic Medicine Institute and founded the Rare Disease Research Consortium. Prior to joining Pfizer, Kevin worked at GlaxoSmithKline (GSK) and, in addition to leading the formation of multiple strategic commercial and academic partnerships, he led epigenetics research and was responsible for the creation of the EpiNova Discovery Performance Unit. Before joining GSK, he lectured at Warwick University Medical School and founded Cambridge Biotechnology (acquired by Biovitrum) and Neurosolutions. Kevin studied pharmaceutical sciences at Nottingham University followed by a Ph.D. in pharmacology at Cambridge University. He undertook postdoctoral training as a Wellcome Trust International Prize Fellow before joining the Parke Davis Research Unit in Cambridge, U.K. Kevin is an author on over 100 peer-reviewed scientific publications, has an MBA from Warwick Business School and has been awarded an honorary Chair in Molecular Pharmacology from the University of Warwick.
Follow Kevin Lee:
About Bicycle Therapeutics: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
_______
Jean-luc Bressard
CEO of Hextransforma Healthcare
Social equality campaigner and entrepreneur
Follow Jean-luc Bressard:
About Dolerite Ltd, Hextransforma Healthcare, Time to Shine Kids: Telemedicine and digital healthcare solution provider. Owner of the Brit-Med.com medical tourism platform
Emil Hewage
Co-Founder & CEO of BIOS
Emil’s academic background is as a PhD researcher in computational neuroscience and machine learning. He brings knowledge of neural signalling and signal processing with over 7 year’s industrial & academic R&D experience. He has previously developed medical devices with Siemens Healthcare and Sphere Medical as well as having held roles in finance and medical and cleantech startups.
Follow Emil Hewage:
About BIOS: A full-stack neural interface platform, that uses AI to decode and encode the signals from to the body, to treat chronic health conditions.
Nader Alaghband
Co-Founder & CEO of Ampersand Health
Follow Nader Alaghband:
About Ampersand Health: Ampersand creates innovative digital medicines for complex long term conditions, using behavioural and data-science.
Sokratis Papafloratos
CEO of Numan
Sokratis Papafloratos works as a Founder and CEO at Togethera. Previously CEO & co-founder of TrustedPlaces, acquired by Yell Group in 2010. Engineering degree from York University.
Follow Sokratis Papafloratos:
About Numan, TrustedPlaces: Numan: Helping Your Health Wherever We Can
John E. Milad
CEO & Founder of Quanta
John E. Milad is a global healthcare executive, board member, investor, speaker and author. He has a career spanning over 25 years, with experience working in various senior positions in the healthcare sector, including NBGI Ventures, Atlas Venture, Nitec Pharma and Nomura. Currently, John is Chief Executive Officer and founding board member at Quanta Dialysis Technologies, where he recently raised $245m in Series D funding. An executive with international experience in building and growing successful healthcare companies, John had the vision and belief that core technology of managing fluidics on a disposable cartridge could be developed into a portable hemodialysis device with the potential to address multiple unmet needs in the $93 billion global dialysis market. John is a regular speaker and panelist at global medtech and investment conferences and has co-authored 4 peer-reviewed papers.
Follow John E. Milad:
About NBGI Ventures, Quanta: Quanta develops an advanced haemodialysis systems for use in the home and clinic.
Ali Rezaei Haddad
CEO and Founder of NeuroNav
Ali is a neurosurgical resident in London and an NHS Clinical Entrepreneur. Prior to this, he completed his Academic Foundation Training in the Medical Sciences Division at the University of Oxford undertaking research in the field of neuroimaging. He graduated with first class honours in Neurosciences BSc at Imperial College London, and he holds honorary research positions at the University of Oxford and St George’s Medical School. Ali co-founded the internationally acclaimed GoodSAM app used by the NHS, in which clinically trained individuals sign up as volunteers to respond to life-threatening emergency calls. He also directed and curated the Imagining the Future of Medicine at the Royal Albert Hall in partnership with TEDMED, attended by a live audience of 5,000 people. Inspired by the lack of user friendly and affordable neuronavigation solutions worldwide, he founded NeuroNav to democratise access to neurosurgery navigation solutions.
Follow Ali Rezaei Haddad:
About Imperial College Healthcare NHS Trust, NeuroNav: An augmented reality neuronavigation platform powered by computer vision and machine learning.
Sina Habibi
CEO of Cognetivity Neurosciences
Sina Habibi is the CEO at Cognetivity Neurosciences.
Follow Sina Habibi:
About Cognetivity Neurosciences: Cognetivity Neurosciences is a Platform technology for early, rapid and easy detection of dementia.
Chas Taylor
Chief Executive Officer & Chairman of Respiratory Motion
Mr. Taylor has over 30 years of experience in the medical technology industry. Recently he was the CEO of Veryan Medical, a Co-founder and Director of Novate Medical, and a Director of BrightWater Medical. All three of these companies were acquired in the last three years. Previously, Mr. Taylor was the Co-founder of MedNova, which was acquired by Abbott Laboratories. Prior to founding and leading these companies, he had a long career with Bard Cardiovascular and General Surgical products where he had roles of increasing responsibility in general management and international sales and marketing.
Follow Chas Taylor:
About : Respiratory Motion ExSpiron is FDA and CE Mark cleared and non-invasively measures minute ventilation, the fundamental unit of breathing.
Carina Cunha
Co-Founder & CEO of Be Nosy
Carina is a business strategist and inventor of Nosy with passion for science, sales and marketing. In her former role as MD and Launcher of Crimson Education Europe, she created sales, marketing and service delivery teams from scratch, achieving millions in ARR and 150%+ YoY growth. Prior to working with startups Carina was corporate strategist at JPMorgan, Strategy Consultant at Accenture, Investment Banker at Credit Suisse, and a fashion model with Elite. Carina is also an innovation and commercial consultant through Meta Strategy and Founders Intelligence where she helps startups and scale-ups find product-market fit and corporates build new revenue lines. She has a B.A. from Columbia University and PgD. from the University of Edinburgh.
Follow Carina Cunha:
About Be Nosy: Nosy is a MedTech startup developing wearable air filter and air pollution tracking network.
Graeme L. Smith
Chief Executive Officer of Lightpoint Medical
Graeme L. Smith is the Chief Executive Officer at Lightpoint Medical.
Follow Graeme L. Smith:
About Lightpoint Medical: Lightpoint Medical, a medical device company, develops intra-operative imaging technology that can detect cancer during surgery.
Tess Cosad
Co-Founder & CEO of Bea Fertility
Tess Isabelle Cosad is the Chief Executive Officer and Co-Founder of Bea Fertility.
Follow Tess Cosad:
About Bea Fertility: Bea Fertility is a monthly subscription program that provides users with at-home fertility treatment and ovulation tracking.
Steve Miller
CEO of KoolZone
Follow Steve Miller:
About KoolZone: KoolZone offers real-time remote monitoring solutions for the hospitality and healthcare industry.
Richard Vincent
CEO & Co-Founder of FundamentalVR
Richard has 20+ years’ experience of building international businesses and has throughout his career sought opportunities for positive market disruption through technological application. It was this desire that led him to co-found FundamentalVR to help address an age-old problem for the medical market; how to create safe, realistic, measurable spaces to learn and develop skills. In his role as CEO Richard is responsible for building a world class team of medical, learning and technologist who together can realise the company’s ambition of creating the world’s first global, haptically enabled, low cost ‘flight simulator for surgeons’.
Follow Richard Vincent:
About Fundamental Surgery, FundamentalVR: FundamentalVR delivers VR haptic ‘flight simulators’ for surgery creating a safe, measurable & repeatable space to refine to refine skills.
Michalis Papadakis
CEO & Co-Founder of Brainomix
Dr Michalis Papadakis is the CEO and co-founder of Brainomix. He leads the management team, commercial strategy, fund raising, and corporate partnerships. He has grown the company from the ground up, building the company’s global presence and has raised over £15 million of private investment and public funding. When he founded Brainomix he was the Scientific Director of the preclinical stroke lab at the University of Oxford. He has a BSc Honours in Biochemistry from Imperial College London and a PhD in neurosciences from UCL School of Pharmacy. He has been an invited speaker at international scientific and innovation conferences
Follow Michalis Papadakis:
About Brainomix: Brainomix specializes in the creation of AI-powered imaging biomarkers that enable precision medicine for better treatment decisions
Jodie Fam
Chief Executive Officer of AblaCare
Jodie brings more than 20 years of medical device experience leading early stage medical device product development, market access and commercialization for major medtech companies and several venture-backed startups. She has been instrumental in bringing a number of early-stage, paradigm-shifting medical technologies to market in diverse and competitive environments. Jodie has held top management roles at Concentric Medical (acquired by Stryker), Medina Medical (acquired by Medtronic), Route 92 Medical and CardioKinetix, as well as senior sales and marketing positions with Johnson & Johnson, Guidant Corporation and Mallinckrodt Medical.
Follow Jodie Fam:
About AblaCare, CardioKinetix, Q’Apel Medical: AblaCare develops an innovative solution for Polycystic Ovary Syndrome (PCOS) related infertility.
Ali Moiyed
CEO & Founder of Aerobit Health
Follow Ali Moiyed:
About Aerobit Health: Breathing New Life Into Asthma Care
Krishan Ramdoo
CEO and Founder of Tympa Health Technologies LTD
Krishan Ramdoo is the CEO and Founder of TympaHealth Technologies.
Follow Krishan Ramdoo:
About Tympa Health Technologies LTD: TympaHealth are a team of doctors and technology experts united in their vision of helping the world to hear.
Thang Vo-Ta
CEO & Co-Founder of Callaly
Co-founder & CEO at Callaly.Thang is a graduate of MIT and started his career in Goldman Sachs in NYC & London.
Follow Thang Vo-Ta:
About Callaly: Callaly is a period care company that develops and manufactures innovative feminine care products.
Emilio Sanz Pereiras
CEO of Acurable
Emilio is a serial entrepreneur and leads Acurable’s strategy, operations and commercialisation activities. Emilio spent the last 15 years building 3 successful start-ups across Europe and Asia, where he learned first hand how to successfully commercialise highly innovative technologies and how to to scale start-up operations in both B2B and B2C industries. Originally from Spain, Emilio holds a MSc in Electrical Engineering from Telecom ParisTech, a MSc in Computer Science from the Polytechnic University of Madrid and an MBA from London Business School.
Follow Emilio Sanz Pereiras:
About Acurable: The first wearable medical device able to accurately diagnose and manage respiratory conditions at home
Soren Krogsgaard Thomsen
Co-Founder, CEO and Managing Director of BioMe Oxford
Soren is a medical scientist at the University of Oxford, with a background in the natural sciences and genetics research. He previously worked as a consultant for pharma and OBR consulting, and has published on his experiences as an academic entrepreneur. Soren’s current research is focused on translating large-scale genetic data into mechanisms for disease to inform new therapeutic strategies. He dreams of one day enabling similar population-wide microbiome studies using the platform technology under development at BioMe Oxford Ltd.
Follow Soren Krogsgaard Thomsen:
About BioMe Oxford, Vertex Pharmaceuticals: Unlocking your gut microbiome by developing a medical device for targeted and non-invasive sampling
Joel Gibbard
CEO of Open Bionics
Joel Gibbard is the founder of Open Bionics and the inventor of the world’s first and most advanced 3D printed robotic hand prosthetic. Joel has won multiple awards for engineering, innovation, and entrepreneurship. Joel was recently named ‘Britain’s Design Engineer of the Year,’ and awarded the Limbless Association’s ‘Prosthetic Innovation of the Year’ award. The roboticist is based inside of the Bristol Robotics Laboratory and is committed to keeping his robotic hands open source.
Follow Joel Gibbard:
About Open Bionics: Open Bionics is a robotics company creating affordable 3D-printed bionic hands for amputees, researchers and makers.
Harry lamble
CEO of Sense Biodetection
Follow Harry lamble:
About Sense Biodetection: Sense Biodetection Limited is a molecular diagnostics company .
Katerina Spranger
Founder and CEO of Oxford Heartbeat
Katerina is the Fellow of the Royal Academy of Engineering. She holds a PhD in Biomedical Engineering from the University of Oxford and was previously a researcher in AI at the Sony Computer Science Laboratory in Paris.
Follow Katerina Spranger:
About Oxford Heartbeat, Royal Academy of Engineering: Oxford Heartbeat makes cardiovascular surgery more accurate and safe.
Ema Kufel
Co-Founder, CEO of Prosoma
Co-Founder/CEO, Ema is an (MSc) Marketing Communications graduate and an expert in healthcare communications. Ema has vast experience in managing projects developing digital strategies within the National Health Service and the Department of Health in the UK. She is passionate about healthcare and innovation, key components of Prosoma.
Follow Ema Kufel:
About Prosoma: At Prosoma, we design world-leading digital therapeutics solutions for Oncology.
Ronan Cunningham
Founder and Chief Executive Officer of BrainWaveBank
Ronan has more than 20 years of experience in advanced engineering and product development. He was one of the founding members of ATA Engineering, an award-winning San Diego-based engineering company specializing in development of innovative hardware and software technologies for the aerospace and defence industries. His roles have included Director of Business Development and Director of New Technology Development. He is an Entrepreneur-in-Residence with the Northern Ireland Science Park. His expertise is in early stage technology development, innovation strategy, and technology commercialisation. He holds an MS in Aeronautics and Astronautics from MIT.
Follow Ronan Cunningham:
About BrainWaveBank, Cumulus Neuroscience: BrainWaveBank makes it possible to measure and track brain activity and cognitive performance for anyone, anytime, anywhere.
Alexandra Hussenot
Founder & CEO of Immersionn
Alexandra is the founder of Immersionn, the world’s first VR Discovery Engine and she is also the UK lead for ‘Women in Immersive Technologies’, a community of 1000 members that aims to empower European women working in XR. She is also 1 in 10 members of the UK5G Creative Industries working group reporting the department in charge of Digital, Medias, Culture and Sport (DCMS). Prior to this, Alexandra pursued an international business career at insurance firm, Allianz, managing an £80M global business. She has also worked all over Europe during her 11 years at Sony Ericsson (now Sony Mobile) and has solid experience designing and launching software and service products, particularly covering user experience design and continuous improvements. She also lead large scale operations for mobile phone repairs and remanufacturing.
Follow Alexandra Hussenot:
About Immersionn: Immersionn is a content discovery company. We allow people to discover VR content they would never find
Colin Story
Co-Founder & CEO of OxSonics Therapeutics
Colin Story brings over 20 years of medical technology and life sciences industrial experience, the majority held in commercial roles. After graduating with a BSc degree in Biological Sciences and a PhD in Molecular Biology he started his career at Amersham plc (now GE Healthcare) in 1997. Initially he held Product Development and Project Management roles in R&D and then latterly held a commercial role where he managed a £20m product portfolio. In 2005 he joined Isis Innovation Ltd, where he initiated, led and concluded a range of multi-£m transactions. In 2008 he went on to recruit and direct a Business Development team that managed over 200 medical science innovations emanating from Oxford University. In 2011 he joined OrganOx Ltd as Operations Director where he handled all operational and contractual aspects of the business that saw the company take a class III medical device from prototype into, and successfully through, first in man clinical trials. In January 2014 he became Co-Founder, Executive Director and the Chief Executive Officer of OxSonics® Ltd.
Follow Colin Story:
About OrthoSon, OxSonics Therapeutics: OxSonics® Therapeutics’ proprietary drug delivery platform technology, SonoTran®
Simos Kedikoglou
Chief Executive Officer of Impulse Dynamics
Simos Kedikoglou is the CEO of Impulse Dynamics since 2013 and serves on the Company’s Board of Directors.He was previously CEO of MedInvest, an Israeli Medical Technology Incubator overseeing 10 portfolio companies with responsibility for their clinical and commercial strategy, technology development and debt and equity financing. He has also served as Corporate Vice President of Business Development for Boston Scientific responsible for acquisitions, licensing and distribution deals in the US, Europe and Asia and an Associate Partner with McKinsey & Company in the US advising clients on acquisitions in pharmaceuticals and medical devices. Simos holds a Medical Degree from the University of Athens, Greece, an MBA with distinction from Harvard Business School as well as a Master’s in Public Health from Harvard University, and he is a CFA Charterholder.
Follow Simos Kedikoglou:
About Impulse Dynamics: Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF).
Harry Destecroix
Founder and CEO of Ziylo
Follow Harry Destecroix:
About Ziylo: Ziylo has developed Biomimetic Glucose Binding Molecules (GBM) for Continuous Glucose Monitors (CGM) & Glucose Responsive Insulins (GRI)
George Frodsham
Founder & CEO of MediSieve
George Frodsham founded MediSieve after being awarded his PhD in biochemical engineering from University College London (UCL), during which he developed the magnetic blood filter. As well as being a physicist and engineer, George is an entrepreneur. George was awarded a BBSRC Enterprise Fellowship from the Royal Society of Edinburgh in 2014. Since 1996, only 180 individuals have benefited from this highly competitive and prestigious programme. George has also completed the Entrepreneurship Summer School programme at the London Business School. This equipped him to research target markets and industries and turn his visions into viable businesses.
Follow George Frodsham:
About MediSieve: MediSieve is a therapeutics company developing a platform technology for the treatment of blood-borne diseases.
Duncan McWilliam
Founder & CEO of VitaeVR
Duncan McWilliam is the founder and CEO of VitaeVR and Outpost VFX.
Follow Duncan McWilliam:
About VitaeVR: Medical devices for early diagnosis of cognitive disease
Ozgur Tuncer
CEO & Executive Director of Stablepharma Ltd
Ozgur Tuncer CEO & Executive Director – two decades of experience in the biopharmaceutical industry including working for blue chip companies such as Pfizer, IQVIA and Pharmacia. Most recently, he was Global Vice President in IQVIA, and strategic adviser to life sciences investors. In addition to his role in Stablepharma, Özgür is an Investment Partner with Ascension Ventures.
Follow Ozgur Tuncer:
About Stablepharma Ltd: An innovative Biotech, developing a wide range of reformulated thermostable and fridge free StablevaX vaccines
Kitty Liao
Founder & CEO of Ideabatic
Royal Academy of Engineering 2018 Enterprise Fellow, Ambassador at THE Port Association, Switzerland. Ten years experience in multi-disciplinary system design and R&D, including low temperature systems, superconducting cavity diagnostics systems and design for low-resource settings.
Follow Kitty Liao:
About Ideabatic: Ideabatic is solving the most challenging humanitarian problems by delivering innovative solutions and devices.
Elliot Street
Co-Founder & CEO of Inovus Medical
Elliot studied medicine at the University of Manchester before completing his foundation training at the Oxford University Hospitals. Alongside his clinical commitments, he retains an active role in product development, bridging the gap between clinician and designer as well as running Inovus’ sales and marketing operations.
Follow Elliot Street:
About Inovus Medical, NHS England: The perfect package for any general surgical trainees or residents.
Christophe Berthoux
Chief Executive Officer of NAMSA
Follow Christophe Berthoux:
About NAMSA: NAMSA is a medical research organization speeding product development for medical devices, IVDs, regenerative medicine.
Clive Morris
President & Chief Executive Officer of Inivata
Follow Clive Morris:
About Inivata: Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.
Eric Mayes
CEO of Endomag
Dr Mayes has over 20 years’ experience in developing and leading materials technology companies. Prior to joining Endomag as CEO in 2010, Eric held executive positions in Cambridge Display Technology (CDT) and NanoMagnetics. He was named the Royal Society of Chemistry’s ‘Entrepreneur of the Year 2003’ for his founding role in NanoMagnetics. Eric is an advisor to the University of Texas at Austin’s ‘Texas Health Catalyst’ and the European Healthtech Translation Advisory Board (HealthtechTAB). A US-UK dual national, he holds a BSc in Physics from Arkansas State University and a PhD in Chemistry from the University of Bath. Eric is a Fellow of the Royal Society of Chemistry.
Follow Eric Mayes:
About Endomag: Endomag is a medical technology company devoted to improving breast cancer care through its magnetic sensing technologies.
Faii Ong
Founder and CEO of GyroGear
Faii Ong is the founder and CEO of GyroGear.
Follow Faii Ong:
About GyroGear: GyroGear is developing a wearable to help individuals with hand tremors.
Damien McDonald
CEO of LivaNova
Damien McDonald is the Chief Executive Officer of LivaNova. Previously, Mr. McDonald served as Chief Operating Officer of LivaNova. Prior to that, he was Group Executive and Corporate Vice President at Danaher Corporation where he led a $1.5-billion group of dental consumables companies. Earlier in his tenure, he was Group President of Kerr where he and his team focused on building a strong research and development pipeline while improving operational performance utilizing the Danaher Business System. Additionally, Mr. McDonald previously led Zimmer’s spine division where he demonstrated his leadership skills, attracting a strong executive team that created a growth trajectory for the business unit. Earlier in his career, he worked with J&J’s Medical Device Franchises, including Ethicon, where he led marketing of the $2.5-billion medical device unit. Mr. McDonald earned an MBA at the Institute for Management Development (IMD) in Lausanne, Switzerland, along with a Master of Science in International Economics from the University of Wales, U.K. He also holds a Bachelor of Economics degree and Bachelor of Pharmacy degree, both from the University of Queensland, Australia. Mr. McDonald is a non-executive director of the regenerative medicine company Avita Medical (ASX:AVH).
Follow Damien McDonald:
About LivaNova: LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment.
Alan Sutherland
Chief Executive Officer of Kind Consumer
Alan Sutherland is the CEO of Kind Consumer.
Follow Alan Sutherland:
About Dyson, Kind Consumer: Kind Consumer is a healthcare research and development company focused on inhalation technologies.
Nick Skaer
Founder and CEO of Orthox Ltd.
Nick Skaer has over 20 years experience in life science and materials research, and 10 years as a medtech CEO raising over £10m to fund development of FibroFix™ technology. In 2008 he founded Orthox with Prof. Oliver Kessler, securing a Translation Award from Wellcome Trust. Since then he has led the scientific and commercial programmes at Orthox, with further awards from the Technology Strategy Board, Wellcome Trust, and NIHR. Before this he was CSO, then CEO of Oxford Biomaterials from 2004 to 2009 where he developed the FibroFix™ technology and implemented the medical device programme. During this period he co-authored 5 patents, including the three assigned to Orthox, secured over £2 million in public grants and private investment and formed 3 spin out companies from Oxford Biomaterials to commercialise biomaterial technologies. Between 1992 and 2003 he studied Molecular Biology at the Universities of Oxford, Cambridge and Strasbourg France, where he obtained his PhD.
Follow Nick Skaer:
About Orthox Ltd.: Orthox develops tissue regenerative implants that address large injuries to cartilage tissues in which early osteoarthritis may be present.
Ann Kramer
CEO of The Electrospinning Company
Ann Kramer is CEO of The Electrospinning Company: a biomaterial platform company with applications in regenerative medicine and medical device markets.
Ann graduated from the University of Cambridge with a degree in Natural Sciences and joined ICI Agrochemicals. Over almost 20 years with ICI, Zeneca and Syngenta she gained experience across the business including in research, sales, business development and M&A, with roles in the UK, USA and Switzerland. She managed the development of genetically modified food business streams in fresh produce crops. Since 2006 she has worked in the SME sector in the UK as Head of Business development for Oxitec Ltd. (acquired by Intrexon in 2015), COO of Immunocore Ltd. and CEO of Biosyntha Ltd. She joined The Electrospinning Company as CEO in 2012.
Follow Ann Kramer:
About The Electrospinning Company: The Electrospinning Company is a provider of electrospun nanofibre innovations, developing solutions to industrial challenges.
Neel Patel
Founder & Chief Executive Officer of ZiO Health
Follow Neel Patel:
About ZiO Health: ZiO Health has developed proprietary pocket-sized technology, bringing lab testing to the point of use.
Samantha Perona
CEO, Founder & Director of Perfectus Biomed
Experienced Chief Executive Officer, PhD, MSC with a demonstrated history of working in commercial research. Skilled in Good Laboratory Practice (GLP), ISO 9001 and 17025. Experience with FDA 510K data generation and MDD/MDR compliance. Strong business development professional with a Goldman Sachs 10,000 small businesses focused in Business.
Follow Samantha Perona:
About Perfectus Biomed: Perfectus Biomed is a U.K.-based biotechnology company providing microbiological services.
Adam Christie
CEO of Calcivis
Adam has a broad background in the pharmaceutical and biotechnology industries. He is a business developer and marketer with direct experience of drug and device development and the capital markets. Previously, as Chief Business Officer at PowderMed, he led business development and commercial strategy which culminated in the successful sale of the company to Pfizer in late 2006, two and a half years after a series ‘A’ venture funding round. Adam is also a Director at MGB Biopharma, another Archangels backed company in Scotland, focused on a new class of antibacterial drugs. His earlier career included roles in business development, marketing and R&D at PPL Therapeutics, GlaxoSmithKline, Abbott Laboratories and Schering AG, and as a City analyst at ABN Amro Hoare Govett. His educational background includes a BSc in Pharmacology from Southampton University and an MBA from Warwick Business School.
Follow Adam Christie:
About Calcivis, MGB Biopharma Limited: Calcivis is a biotech company that focuses on unmet needs in dentistry.
Herbert Oakes
Founder & CEO of NOXSUDOR THERAPEUTICS LIMITED
Herbert Oakes, non-executive director, is an investment banker and builder of high technology life sciences companies. He is currently a Managing Director of Oakes, Lyman & Co. Limited an investment banking firm specialising in high-tech healthcare; a Managing director of Hycroft Advisors, a global investment banking firm specialising in arranging capital for private equity partnerships; and CEO of NoxSudor Therapeutics Limited, a start-up medical business developing a therapy for hot flashes and night sweats for menopausal women. He is an advisor of Wilton Corporate Finance Limited.
Follow Herbert Oakes:
About NOXSUDOR THERAPEUTICS LIMITED: First prescription medical device to control sweating
Toby Basey-Fisher
Co-Founder & CEO of Entia
Toby Basey-Fisher serves as a Co-Founder & CEO at Entia.
Follow Toby Basey-Fisher:
About Entia, Imperial College London: Entia is a medical technology company that specializes in improving access to blood test.
Hugh Cormican
CEO of Cirdan
Hugh, a founder of Cirdan, studied physics at Queens University Belfast. Also a founder and Director of Andor Technologies Plc, he was awarded an Honorary Doctorate by QUB in 2003. During his PhD studies Hugh became involved in the start-up of Andor Technology. In 2000 he was awarded the Institute of Physics Paterson medal and prize for commercialization of Physics in recognition of the success of Andor.
Follow Hugh Cormican:
About Cirdan: Cirdan delivers solutions that enable rapid implementation of a robust and scalable digital pathology workflow into a laboratory.
Kadem Al-Lamee
CEO of Arterius
Kadem Al-Lamee, CEO, Arterius Limited, was a co-founder of PolyBioMed Limited in 1996, serving as Technical Director before becoming Managing Director in 2001, when PolyBioMed was acquired by Lombard Medical Technologies. PolyBioMed was recently purchased by Bayer Materials Science. Dr Al-Lamee was integral to the development of the business throughout its history, including strategic development, fund-raising, technical development and the establishment of its intellectual property portfolio. Previously he was Principal Scientist in polymer chemistry for Innovative Technologies plc, managing research and development programmes in areas including wound dressings and coated urinary catheters. Dr Al-Lamee has extensive research and teaching experience with an MSc and PhD in Polymer Chemistry from the University of Liverpool. He has over 30 years experience in Biomaterials and Medical Devices, has published over 50 papers in international journals and holds 25 granted patents/patent applications. Dr Al-Lamee’s main interests are biomaterials, surface modifications and the coating of materials commonly used in medical devices, drug delivery systems, hydrogels for medical applications, cardiovascular devices, wound-care products, urology and tissue engineering devices. He has been successfully awarded many grants from the UK’s DTI, the Innovate UK, Yorkshire Forward, and European Commission for the research and development of healthcare projects.
Follow Kadem Al-Lamee:
About Arterius: Arterius developing a novel next-generation polymer-based Bio-resorbable Coronary Scaffold (BRS), more commonly known as a ‘stent’.
Anna Starynska
CEO of Cardiolyse
Follow Anna Starynska:
About Cardiolyse: Cardiolyse is a cloud ECG & HRV analytics platform that provides personalized reports, heart failures detection, and data-based prognosis.
Paul Cook
CEO of Healthium Medtech
Paul Cook is the CEO at Healthium Medtech.
Follow Paul Cook:
About Healthium Medtech: Healthium MedTech manufactures and sells a broad range of medical devices and consumable products.
Michal Wlodarski
Chief Executive Officer of Solvemed Group
Cambridge PhD with 8+ years of diverse experience in life sciences spanning emerging technology consulting, venture management, business development, knowledge and technology transfer, academic and industrial R&D, and teaching and mentoring at the graduate level. 5+ years of experience in healthcare & life sciences consulting with a strong skill set spanning business development and sales, client and project management, and expert team leadership across R&D strategy, technology forecasting and scouting, product innovation and technology commercialisation projects. Demonstrated consistently the ability to initiate and develop successful professional relationships, generate new revenue streams, manage diverse stakeholders and expert teams, and lead the delivery of complex high-stake life science innovation projects in high-pace international environments.
Follow Michal Wlodarski:
About Solvemed Group: Revolutionising neurology diagnostics and drug discovery with the power of Artificial Intelligence.
Chris Ball
Chief Executive Officer of Jupiter Diagnostics
Prior to founding Jupiter Diagnostics, Chris launched point-of-care diagnostic tests for Johnson & Johnson in Europe. He has worked as a CEO of a Boston biotech company, as a venture capital investor and a doctor. He has raised more than £40 million for companies he has supported or led.
Follow Chris Ball:
About IQVIA, Jupiter Diagnostics: Jupiter Diagnostics has developed a diagnostic platform
Clive Minihan
CEO of Test & Treat
Clive Minihan is the Chief Executive Officer of Test & Treat.
Follow Clive Minihan:
About Test & Treat: Test & Treat is a medical device company that manufactures and supplies company to worldwide veterinary markets.
Ashmita Das
Co-founder and CEO of Kolabtree
Follow Ashmita Das:
About Kolabtree: Find & hire experts, top postdocs & PhDs, as research collaborators for your academic or business projects.Speed up your research work!
Hugh Lloyd-Jukes
CEO and Chairman of Oxehealth
Hugh Lloyd-Jukes is the CEO and Chairman at Oxehealth.
Follow Hugh Lloyd-Jukes:
About Oxehealth: SaaS workflow solution gives carers and custodians more time for hands on care where and when it’s needed most.
Tristan Collins
CEO of GaitQ
Tristan Collins serves as the Chief Executive Officer at GaitQ.
Follow Tristan Collins:
About GaitQ: GaitQ is a developer of a medical device used to help people living with Parkinson’s disease to overcome freezing of gait.
Neciah Dorh
Co-Founder and CEO of FluoretiQ
Neciah Dorh is a Co-Founder and serves as the Chief Executive Officer at FluoretiQ.
Follow Neciah Dorh:
About FluoretiQ: FluoretiQ is a medical device company designing simple and effective bacterial detection systems for rapid diagnosis of infection.
Rajarshi Banerjee
Chief Executive Officer & Founder of Perspectum
Rajarshi Banerjee is CEO of Perspectum, which he co-founded in 2012, and now employs over 100 people in Oxford, Singapore and San Francisco. Rajarshi has worked in the National Health Service since 2002, and trained in cardiology and internal medicine in London and Oxford. He developed the MR techniques for rapid non-invasive liver assessment in Oxford, and commercialized the method as LiverMultiScan, which is now FDA cleared and used in over 200 sites. He graduated in medicine from Oxford, and went on to complete a Masters in Public Health in London before returning to Oxford for his doctorate. Dr Banerjee continues to work as a Consultant Physician with Oxford University Hospitals NHS Foundation Trust, with research into the phenotyping of liver disease at an individual and population level in adults and children. He has many years of experience in running clinical trials and working in multidisciplinary scientific teams to develop applications for cutting-edge imaging technology and is a keen advocate of smart trial design.
Follow Rajarshi Banerjee:
About Perspectum: Healthcare, Medical Technology, SaaS
Nadia Whittley
Chief Executive Officer of Arquer Diagnostics
Follow Nadia Whittley:
About Arquer Diagnostics: Arquer Diagnostics is a diagnostics company focused on the development and commercialisation of a non-invasive immunoassay diagnostic test.
Jon Holmes
Co-Founder and CEO of Michelson Diagnostics
Under Jon’s skilful and visionary leadership, Michelson Diagnostics Ltd has rapidly grown from a fledgling start-up in 2006, to the thriving company it is today. He has masterminded five rounds of investment, and his strategy for growth has enabled the company to achieve all of its milestones to date, on time and on budget.Jon was previously Business Director of the Biomedical Group at Sira, the instrumentation R&D company, and was Director of the Smart Optics Faraday Partnership.
Follow Jon Holmes:
About Michelson Diagnostics, Michelson Diagnostics, SmartOptics: Michelson Diagnostics develops and manufactures multi-beam Optical Coherence Tomography-based products.
Mark Street-Docherty
Chief Executive Officer of MicrosensDx
Follow Mark Street-Docherty:
About MicrosensDx: MicrosensDx focuses on delivering the sample result in molecular solutions that transforms patient outcomes.
David Hughes
CEO of CN Bio Innovations
Dr Hughes joined CN Bio Innovations in 2010 as Head of Engineering, was promoted to Technical Director in 2013 with responsibility for the management of all in-house and collaborative research and development programmes and the contract research services business. Dr Hughes was subsequently promoted to Chief Technology Officer in July 2014 with responsibility for managing the technical programs with the company’s academic and industrial partners. and, in 2018, he was promoted to CEO. During his career at CN Bio, he has secured and overseen the successful delivery of government and pharmaceutical research contracts and research grants totalling more than £2Mi.
Follow David Hughes:
About CN Bio Innovations: CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
David Hughes
CEO of CN Bio Innovations
Dr Hughes joined CN Bio Innovations in 2010 as Head of Engineering, was promoted to Technical Director in 2013 with responsibility for the management of all in-house and collaborative research and development programmes and the contract research services business. Dr Hughes was subsequently promoted to Chief Technology Officer in July 2014 with responsibility for managing the technical programs with the company’s academic and industrial partners. and, in 2018, he was promoted to CEO. During his career at CN Bio, he has secured and overseen the successful delivery of government and pharmaceutical research contracts and research grants totalling more than £2Mi.
Follow David Hughes:
About CN Bio Innovations: CN Bio develops human organ-on-a-chip platforms for the testing and development of therapeutics for serious human diseases.
Charles Large
Founder and CEO of Autifony Therapeutics
Charles Large received his first degree and PhD from the University of Bristol and has more than 20 years of experience of drug discovery and development in the pharmaceutical industry. Before founding Autifony, he was Director of Molecular and Cellular Biology within the Neuroscience Centre of Excellence for Drug Discovery at GlaxoSmithKline, and has worked on programs focused on schizophrenia, Alzheimer’s disease, epilepsy, bipolar disorder, and major depression. He is an expert on drugs that modulate voltage gated ion channels and their application to neurological and psychiatric disorders. He has built up a reputation in the field of sodium channel blocking drugs, and has collaborated widely with academic groups. He has authored over 50 papers, book chapters and patents relating to ion channel modulators.
Follow Charles Large:
About Autifony Therapeutics: Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Billy Boyle
CEO and Co-Founder of Owlstone Nanotech
Since co-founding Owlstone, Billy has been overseeing the development and implementation of the detection technology with nanotechnology foundry partners. He is also active in business development, demonstrating to partners how the Owlstone technology can used to realise a paradigm shift in detection applications and deployment scenarios. Billy is heavily involved in the creation and realisation of new technologies and IP. Prior to joining Owlstone Billy was a Research Associate in the Microsystems and Nanotech group at Cambridge University. In an academic / industry consortium he designed and developed silicon-opto hybrid devices for next generation telecoms systems.
Follow Billy Boyle:
About Owlstone Nanotech: OWLSTONE is a platform technology, where regardless of the application, hardware remains the same & the app is enabled through software.
Kosta Mavroulakis
Founder and CEO of Empact Ventures
Follow Kosta Mavroulakis:
About Empact Ventures: Empact Ventures co-designs some of the leading startup, tech and non-profit initiatives for large private or public sector organisations
Steve Parker
CEO of Creavo Medical Technologies
Follow Steve Parker:
About Creavo Medical Technologies, The Open University: Creavo Medical Technologies is an innovative British company developing diagnostics technology for acute medical settings.
Tim Clover
Chief Executive Officer of Rayner Surgical Group
Tim joined the Rayner Group Board in May 2014. Tim has spent many years in the ophthalmic market and brings to Rayner extensive knowledge of medical devices, ophthalmic services and strategic investment. Tim was a founder and European VP of Advanced Medical Optics which was spun out of Allergan Inc, listed on the NYSE and subsequently acquired by Abbott Inc. More recently he was CEO of Moonray Healthcare, a private equity fund within Fidelity Worldwide Investments in which Optegra was a landmark investment. Tim led a team which grew Optegra into a leading worldwide provider of eye surgery centres operating from 23 specialist eye hospitals across Europe and Asia. Tim has a passion for swimming, cycling and running and regularly competes in triathlons.
Follow Tim Clover:
About Rayner Surgical Group: Rayner Surgical Group is manufactures Intraocular lenses and associated instruments used in cataract surgery.
Vaclav Potesil
CEO of Optellum
Follow Vaclav Potesil:
About Optellum: Optellum develops an imaging biomarker for smart lung cancer detection.
Richard Hancock
Chief Executive Officer of Blue Maestro
Richard Hancock joined Blue Maestro as Chief Executive Officer in 2012.
Follow Richard Hancock:
About Blue Maestro: Environment and health monitoring solutions from developing innovative Bluetooth devices to hosting a cloud platform for sensor telemetrics.
Joanna Burnett
Co-founder and CEO of GPrX Data
Follow Joanna Burnett:
About GPrX Data: GPrX Data translates NHS practice level prescribing data into easily-reviewed intelligence.
Hugo Macedo
CEO & Founder of Smart Separations Ltd
Hugo is the founder and CEO of Smart Separations Ltd. He has over 11 years of experience in entrepreneurship which helped him founding this start-up company that has developed a proprietary filter that can be tailored to suit many different applications in the poorly explored but very large microfiltration market, from biotechnology to food & drink processing. Throughout his PhD in Biomedical Engineering, Hugo was constantly challenged with new and diverse tasks, in a multidisciplinary environment, where he breathed skills from chemical engineering to stem cell technology, including membrane technology, hydrodynamics, stem cell culture and bioprocessing, human blood production, amongst many others. This provided him with the right tools to create the first “3D hollow fibre bioreactor for the production of human red blood cells” – a system design that he patented. This work was featured in different magazines, including the cover page of The Chemical Engineer (TCE) in 2011, selected as one of “Ten life-changing ideas under research at UK universities” by the Research Councils UK and shortlisted for the highly prestigious IChemE Awards in 2011. Hugo currently holds 2 patents and is passionate for innovation leading to improve people’s quality of life – a vision that he has shared with Smart Separation
Follow Hugo Macedo:
About Smart Separations Ltd: Smart Separations is a limited company based in London UK that has patented an innovative microfiltration technology.
David Fried
Chief Executive Officer of Evolv
Follow David Fried:
About Evolv: Evolv is a medical device manufacturer that specialises in developing rehabilitation technology solutions.
Sukhbinder Noorpuri
Founder & CEO of i-GP
With over 15 years of NHS experience, Dr Noorpuri founded i-GP to improve patient access to care that is convenient, affordable and safe.
Follow Sukhbinder Noorpuri:
About i-GP: i-GP is an online service that provides customers with medical services and advice.
Andrew Baker Campbell
CEO of LEX Diagnostics
Andrew Baker-Campbell is the CEO of LEX Diagnostics.
Follow Andrew Baker Campbell:
About LEX Diagnostics: LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care.
Andrew Baker Campbell
CEO of LEX Diagnostics
Andrew Baker-Campbell is the CEO of LEX Diagnostics.
Follow Andrew Baker Campbell:
About LEX Diagnostics: LEX Diagnostics is a medical device company that specializes in molecular diagnostics for primary care.
David Jackson
CEO of Oxtex
Follow David Jackson:
About Oxtex: Oxtex Limited, a medical device company, manufactures anisotropic self-inflating tissue expanders that is based on hydrogel technology.
David Jackson
CEO of Oxtex
Follow David Jackson:
About Oxtex: Oxtex Limited, a medical device company, manufactures anisotropic self-inflating tissue expanders that is based on hydrogel technology.